LJM 1993-2820 1819-6357 Libyan Journal of Medicine, Vol. 6, No. 00, September 2011, pp. 1–5 sici xxx PUBMED Abbreviation Yousef A. Taher

*Yousef A. Taher Department of Pharmacology and Clinical Pharmacy Faculty of Pharmacy Tripoli UniversityP.O. Box 83001 Central Post Tripoli Libya + 218 92 3022980 + 218 21 4625577

Abas Hj Hussin Department of Pharmacology and Clinical Pharmacy Tripoli University

Tripoli Libya

School of Pharmaceutical Sciences Universiti Sains Malaysia

11800 Pulau Pinang Malaysia

Libyan Journal of Medicine ORIGINAL ARTICLE Influence of FUB on aminopyrine metabolism Traditional medicines, in particular herbal products, have been used abundantly over the years in curing several diseases. Pharmacological interactions of herbal products with modern drugs, however, remain to some extent unknown. Herein, we examined whether co-administration of Faizol Ubat Batuk (FUB), a mixture of aqueous extract of different plants, modifies the metabolism of aminopyrine, a conventional analgesic drug, in rat liver. We used rat hepatocytes outfitted by collagenase perfusion technique. Determination of aminopyrine n-demethylase activity was performed using the Nash colorimetric method, by measuring the amount of formaldehyde produced. Compared to control treatment, FUB significantly increased the hepatic metabolism of aminopyrine in healthy adult male rats. In contrast, the hepatic metabolism of aminopyrine in adult female rats was decreased. Besides, a biphasic effect in n-demethylase activity was observed in young male rats treated with FUB. In a subsequent experiment, FUB did not change the metabolism of aminopyrine in streptozotocin (STZ)-diabetic adult male rats. In conclusion, administration of FUB could affect phase I aminopyrine metabolism in rat heptocytes. In addition, the effects of FUB on hepatic n-demethylase activity were gender and disease dependent. drug metabolism hepatocytes herbal products gender diabetes mellitus The herbal product Faizol Ubat Batuk (FUB). All chemicals used were of analytical grade purity. Collagenase (type IV), streptozotocin (STZ), and aminopyrine were obtained from Sigma Chemical Co. (St. Louis, MO, USA). The FUB was purchased from Faizol Industri, sdn. Bhd. Kuala Kangsar, Malaysia. The compositions of FUB were as follows: Duan Perya 5%; Daun Asam Jawa 10%; Buah Kembang Semangkuk 10%; Buah Bemban 5%; Lobak Ubi 20%; Agar-agar 14%; Rumput Laut 5%; Menthol 1%; Umbut Pisang 5%; Getah Angur 10% and Madu 15%. Healthy adult male and female (18–20 weeks old; 210–290 g; n=6 each group) and young male (8–10 weeks old; 85–103 g; n=6) rats of the Sprague Dawley (SD) strain were used. The rats were obtained from the animal house, Pharmacy Discipline, Universiti Sains Malaysia (USM), Pinang, Malaysia. The animals were housed in macrolon cages in laminar flow cabinet, 2–4 animals per cage, under standard environmental condition, and provided with food (Gold Coin) and water ad libitum. Animal care and use were conducted in accordance with the Animal Ethics Committee of USM, Malaysia, 1998. The STZ-induced diabetes has been demonstrated to affect drug metabolism. Herein, hyperglycemia was induced by intravenous injection of STZ (60 mg/kg) in distilled water, via rat-tail. Increased blood glucose level was confirmed on the third day after administration of STZ. Animals (n=6) showed high blood glucose levels (higher than 300 mg/dl at fasting state), measured by using Extac Tech glucometer (Medisense, USA) 6. The protocol used for isolation of hepatocytes was performed by using the modified collagenase perfusion technique as previously described 7 8 9 . Rats received orally equal volume of serial dilutions of FUB in water, ranging from one tenth to one tenth million on day zero. The STZ-diabetic rats received FUB on day 4 post-STZ injection. Control rats were treated the same but had the FUB replaced with water. Twenty four hours after the administration of FUB, rats were anaesthetised with ether and the liver perfused in situ through the hepatic portal vein with calcium-free Hank's Balanced Salt Solution (HBSS) for 15 min. Hereafter, the collagenase buffer (HBSS supplemented with 4 mM calcium chloride and collagenase 0.5 mg/ml) was perfused until the liver appeared to have broken up. The liver was removed from the animal, and the cells were dispersed in calcium-free HBSS using steel forceps. The cell suspension was filtered through gauze and centrifuged at 200×g for 5 min (in a Hettich Universal Centrifuge) to clean the parenchymal cells of debris. The supernatant was drained out, and the cells were resuspended in incubation medium (HBSS supplemented with 1 g/L glucose, 100 mg/L MgSo₄, 100 mg/L MgCl₂ and 185 mg/L CaCl₂; pH 7.4). The cells were then counted using a haemocytometer and assayed for viability using trypan blue exclusion method. The average yield was 5×10⁷ cells/g liver, and viability was routinely greater than 90% for all preparations. Then, the cells were plated out on 90-mm petri dishes (Medical Product, Malaysia) at a density of 6×10³ cells/10 ml incubation medium as previously described 10. Aminopyrine dissolved in distilled water was added directly to the petri dish at a final concentration 250 mmol/L. The experiment was done in quadruplicates. Petri dishes were then shaken using a table top shaker (Belly Dancer, Stoval, USA) and incubated in CO₂ incubator (Queue Systems Inc. Model 2710) for 18 min at 37°C 7 8 10. Aminopyrine n-demethylase activity was measured at 415 nm to determine the quantity of formaldehyde formed according to the colorimetric method of Nash 11. Aminopyrine n-demethylase activity is expressed in nmol/min/million cells. Data are expressed as mean enzyme activity±SEM. The statistical significance of the differences was assessed using the Student's t-test. In all the cases, a probability value P < 0.05 was considered statistically significant. Analyses were performed by using GraphPad Prism (GraphPad Software Inc., version 3.0, San Diego, USA). In contrast to allopathic remedy where the content and dose of active ingredient in any dosage form is well quantitated, the pharmacological actions using herbal medical preparations are derived from the effects of the total ingredients. In the present study, findings indicated that co-administration of FUB, a multiple herbal ingredient concoction traditionally used to treat common cold diseases, changed the hepatic phase I metabolism of aminopyrine in rat liver. Aminopyrine undergoes phase I n-demethylation in the liver in the presence of cytochrome P-450 n-demethylase. Studies in rat hepatocytes showed that the hepatic n-demethylase enzyme activity can be, indirectly, determined throughout the aminopyrine metabolism by measuring the quantity of formaldehyde formed 12. The present study showed that the metabolism of aminopyrine is changed in the presence of FUB. Compared to control-treated rats, FUB significantly increased the in vitro hepatic metabolism of aminopyrine in adult male rats by 30% (P < 0.05, Fig. 2), indicating the induction of hepatic enzyme activities following treatment with this traditional medicine, FUB. However, this increase in n-demethylase activity was not dose dependent because increased FUB concentrations did not increase further the hepatic phase I metabolism of aminopyrine (Fig. 2). In addition, the effect of FUB on n-demethylase enzyme activity was gender dependent. In adult female rats, co-administration of FUB did significantly reduce (21% decrease, P < 0.05, Fig. 2) the aminopyrine n-demethylase activity. Therefore, these results show that FUB alters aminopyrine metabolism, and that this effect is gender dependent.

Dose–response effect of FUB on aminopyrine metabolism in hepatocytes obtained from healthy adult male rats (•), healthy adult female rats (▪), healthy young male rats (▴), STZ-diabetic male rats (♦). Each dose done in quadruplicate, n=6 each. Control: hepatocytes obtained from matched animal group treated with distilled water. Values are expressed as percentage of the relevant control±SEM. * P < 0.05 compared to their respective control.

In young male rats, our data showed that FUB has biphasic effects, increased the enzyme activity at lower concentrations, while at higher concentrations FUB reduced the metabolism of aminopyrine in rat hepatocytes (Fig. 2). As can be seen from figure 2, young male rats responded similarly to adult male rats to FUB mainly at lowest concentrations at above 1:100,000 dilutions, indicating that the influence of FUB on aminopyrine metabolism is not affected by age. Nonetheless, as in normal and young male rats, the observed effects varied depending on the concentrations used age factor has a significant effect on FUB influence, mostly at highest concentration at beneath 1:10,000 dilutions, on aminopyrine metabolism. In contrast, difference in rat gender has a significant effect on FUB influence on hepatic phase I n-demethylase activity at all tested FUB dilutions (Fig. 2). In a different study, our findings showed that 1-day oral administration of FUB showed little effect on the metabolism of aminopyrine in adult male STZ-diabetic rats compared to STZ-diabetic control rats (Fig. 2). The total amount of formaldehyde formed (in absolute value) is shown in Table 1. Therefore, in addition to being gender dependent, it seems that the influence of FUB on aminopyrine n-demethylase activity is also disease dependent since the n-demethylase activity being markedly enhanced in healthy rats while less affected in STZ-diabetic rats. n-Demethylase activity (nmol formaldehyde formed/min/million cells) Dilution Adult male rats Diabetic male rats Note: Results are expressed as mean enzyme activity±SEM. Each dose done in quadruplicate, n=6. Control had FUB sample dilutions replaced with distilled water. * P < 0.05 compared to their respective control group. Control (water) 500.45±05.25 671.76±24.99 FUB 1:10,000,000 624.30±05.53* 725.24±29.38 FUB 1:1,000,000 658.55±28.25* 701.40±19.13 FUB 1:100,000 570.13±07.16* 627.55±14.41 FUB 1:10,000 572.45±15.92* 641.67±09.12 FUB 1:1,000 614.35±04.55* 660.88±19.59 FUB 1:10 621.53±09.11* 715.05±20.20 The present study displayed that FUB differently affects the aminopyrine n-demethylase enzyme activity. However, it is not known which of the plant extract used in the concoction of FUB is responsible for those observed effects. Moreover, the mechanisms by which FUB changes the metabolism of aminopyrine are not known at present. Since in vitro incubation of FUB with rat liver hepatocytes did not change the metabolism of aminopyrine (data not shown), a direct affect of FUB on the n-demethylase enzyme activity is probably not at play. Hence, it seems likely that FUB changes the cytochrome P450 activity by indirect mechanisms. Moreover, it cannot be totally excluded that the in vivo effects of FUB are rather related to its actions on other physiological systems. Several studies have demonstrated that cytochrome P450 activity is changed after phosphorylation 13 14. Therefore, it appears likely that while FUB, dose independently, changed the cytochrome P450 activity, FUB phosphorylated cytochrome P450 in male rats and de-phosphorylated cytochrome P450 in female rats. Our present data are in agreement with other studies, demonstrating that a change in aminopyrine metabolism is sex dependent 15 16 17 . Age differences in pharmacokinetics and hepatic drug metabolism had been well documented in rodent models 18 19. Similarly, de Wildt and his colleagues extrapolate those findings in human studies 20. In the present study, our findings are not completely in line with the studies 18 19, since the metabolism of aminopyrine in adult male rats is not significantly different from that in young male rats, mainly at FUB lower concentrations. One likely explanation for this discrepancy may be that the other studies 18 19 used a direct in vitro incubation of aminopyrine with herbal extract, whereas we treated our rats systemically with FUB. Various other studies have indicated that diabetes produce substantial changes in intracellular metabolism in most tissues including liver and play a significant role in drug metabolism 16 21. In agreement with the literature, our findings showed that the hepatic metabolism of aminopyrine is slightly affected in diabetic rats while significantly enhanced in non diabetic (healthy) rats 22 23. These findings provide further support for contributing this biological factor in drug metabolism. The present study indicates that co-administration of FUB preparations was able to manipulate the hepatic metabolism of aminopyrine in rat liver. A possibility exists that interactions occur with other drugs that undergo hepatic phase-I n-demethylation process, such as imipramine, chlorpromazine, morphine, and phenothiazine, and uncertainly reduces their bioavailability. Moreover, it is apparent that gender and induced diabetes modifies the effect of FUB. A likely, but only at higher concentrations, the influence of FUB on aminopyrine metabolism was age dependent. Whether the results obtained are similarly reproduced in humans still needs further investigation. Y.A.T was supported by a grant 4-1994 from the Libyan Ministry of Higher Education. World Health Organization ( 2001 ). Legal status of traditional medicine and complementary/alternative medicine: a worldwide review. WHO Technical Report Series, Geneva, Switzerland. World Health Organization ( 2002 ). WHO Traditional Medicine Strategy 2002–2005. WHO Technical Report Series, Geneva, Switzerland. Briggs D. The regulation of herbal medicines in Australia. Toxicology. 2002; 181–812: 565–70. Zhou S Gao Y Jiang W Huang M Xu A Paxton JW. Interactions of herbs with cytochrome P450 Drug Metab Rev 2003 35 35 98 Yang X Kulkarni AP. N-dealkylation of aminopyrine catalyzed by soybean lipoxygenase in the presence of hydrogen peroxide J Biochem Mol Toxicol 1998 12 175 83 Robert W Flint J. Emotional arousal, blood glucose levels and memory modulation: three laboratory exercises in cognitive neuroscience J Undergrad Neurosci Edu 2004 3 A16 23 Han C Abas H Sabariah I. Effect of Orthosiphon stamineus leaf extracts on hepatic cytochrome P450, UGT and GST activity in STZ-induced diabetic rats JASA 2009 1 1 8 Hussin A Skett P. Lack of effect of insulin in hepatocytes isolated from streptozotocin-diabetic male rats. Biochem Pharmacol 1988 37 1683 6 Jagoda R Josip R. Effects of vanadate on oleic acid induced insulin resistance in cultured rat hepatocytes Diabetologia Croatica 2004 33 17 21 Taher Y, Hussin A. In-vitro effect of a herbal product on aminopyrine metabolism in rat hepatocytes. Fitoterapia. 1998; LXIX: 265–68. Nash T. The colorimetric estimation of formaldehyde by means of the Hantzsch reaction Biochem J 1953 55 416 21 Purwantiningsih, Abas HH, Kit L. Phase I drug metabolism study of the standardized extract of Eurycoma longifolia (TAF273) in rat hepatocytes. Int J Pharm Pharmac Sci. 2010; 2: 147–52. Oesch-Bartlomowicz B Oesch F. Cytochrome-P450 phosphorylation as a functional switch Arch Biochem Biophys 2003 409 228 34 Oesch-Bartlomowicz B Oesch F. Phosphorylation of cytochromes P450: first discovery of a posttranslational modification of a drug-metabolizing enzyme Biochem Biophys Res Commun 2005 338 446 49 Lin G Cui Y Liu X. Gender differences in microsomal metabolic activation of hepatotoxic clivorine in rat. Chem. Res Toxicol 2003 16 768 74 Skett P Joels L. Different effects of acute and chronic diabetes mellitus on hepatic drug metabolism in the rat. Biochem Pharmacol 1985 34 287 9 Xu M Wang G Xie H Li H Huang Q Wang R Gender difference regarding schizandrin pharmacokinetics in rats Eur J Drug Metab Pharmacokinet 2008 33 65 8 Han CJ Abas HH. Effect of the Orthosiphon stamineus benth on aminopyrine metabolism in rat hepatocytes Malaysian J Pharmaceutical Sciences 2007 5 25 32 Koch KM Palmer JL Noordin N Tomlinson JJ Baidoo C. Sex and age differences in the pharmacokinetics of alosetron Br J Clin Pharmacol 2002 53 238 42 de Wildt SN Trevor NJ Imti C. The effect of age on drug metabolism Paediatr Perinat Drug Ther. 2003 5 101 6 Khalid M. Influence of overt diabetes mellitus on cyclosporine pharmacokinetics in a canine model Exp Diabetes Res. 2009 2009 1 6 Cheng P Morgan E. Hepatic cytochrome P450 regulation in disease states Curr Drug Metab 2001 2 165 83 Schenkman J. Induction of diabetes and evaluation of diabetic state on P450 expression Methods Enzymol 1991 206 325 31